Intervention not reported
0.05 mg/d · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
0.1 mg/d · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
0.2 mg/d · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
0.3 mg/d · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
0.4 mg/d · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
0.8 mg/d · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
CI: confidence interval · participants with normal or abnormal lipid profiles
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
aMean baseline values. · participants with normal or abnormal lipid profiles
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Cerivastatin dose · participants with normal or abnormal lipid profiles
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
0.05 mg/d · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
0.05 mg/d · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
0.1 mg/d · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
0.2 mg/d · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
0.3 mg/d · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
0.4 mg/d · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
0.8 mg/d · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
CI: confidence interval · participants with normal or abnormal lipid profiles
The review found no eligible studies for this question.
1 finding from 1 review
Withdrawals due to adverse events · participants with normal or abnormal lipid profiles
It is very uncertain whether all doses of cerivastatin changes withdrawals due to adverse events compared with placebo (very low certainty).
1 finding from 1 review
Intervention not reported
0.1 mg/d · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
0.2 mg/d · participants with normal or abnormal lipid profiles
1 finding from 1 review